| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.33e-06 | 37 | 192 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.56e-06 | 38 | 192 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity, type I | 8.63e-06 | 5 | 192 | 3 | GO:0005025 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | SLK ERN1 PBK ERVK-10 ACVR1 PFKFB4 RPS6KC1 STK32A BMPR1A BMPR1B CSNK1G1 MAP4K4 REV1 MAP3K8 POLR2B POLR2G MAP3K14 OAS2 PDPK2P CSNK1G2 N4BP2 ERVK-8 PRKCZ MUSK | 1.22e-05 | 938 | 192 | 24 | GO:0016772 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | SLK ERN1 PBK ACVR1 RPS6KC1 STK32A BMPR1A BMPR1B CSNK1G1 MAP4K4 MAP3K8 MAP3K14 PDPK2P CSNK1G2 PRKCZ | 2.86e-05 | 446 | 192 | 15 | GO:0004674 |
| GeneOntologyMolecularFunction | BMP receptor activity | 4.73e-05 | 8 | 192 | 3 | GO:0098821 | |
| GeneOntologyMolecularFunction | methionine adenosyltransferase activity | 9.20e-05 | 2 | 192 | 2 | GO:0004478 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | SLK ERN1 PBK ACVR1 PFKFB4 RPS6KC1 STK32A BMPR1A BMPR1B CSNK1G1 MAP4K4 MAP3K8 MAP3K14 PDPK2P CSNK1G2 N4BP2 PRKCZ MUSK | 1.76e-04 | 709 | 192 | 18 | GO:0016773 |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity | 2.33e-04 | 13 | 192 | 3 | GO:0005024 | |
| GeneOntologyMolecularFunction | protein kinase activity | SLK ERN1 PBK ACVR1 RPS6KC1 STK32A BMPR1A BMPR1B CSNK1G1 MAP4K4 MAP3K8 MAP3K14 PDPK2P CSNK1G2 PRKCZ MUSK | 2.35e-04 | 600 | 192 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | endonuclease activity | 3.50e-04 | 136 | 192 | 7 | GO:0004519 | |
| GeneOntologyMolecularFunction | kinase activity | SLK ERN1 PBK ACVR1 PFKFB4 RPS6KC1 STK32A BMPR1A BMPR1B CSNK1G1 MAP4K4 MAP3K8 MAP3K14 PDPK2P CSNK1G2 N4BP2 PRKCZ MUSK | 4.31e-04 | 764 | 192 | 18 | GO:0016301 |
| GeneOntologyMolecularFunction | 3' overhang single-stranded DNA endodeoxyribonuclease activity | 5.45e-04 | 4 | 192 | 2 | GO:1990599 | |
| GeneOntologyMolecularFunction | hyaluronan synthase activity | 5.45e-04 | 4 | 192 | 2 | GO:0050501 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | SLK ERN1 PBK RPS6KC1 STK32A CSNK1G1 MAP4K4 MAP3K8 MAP3K14 CSNK1G2 PRKCZ | 8.08e-04 | 363 | 192 | 11 | GO:0106310 |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase activity | 8.84e-04 | 20 | 192 | 3 | GO:0004675 | |
| GeneOntologyMolecularFunction | endopeptidase activity | BACE1 ERVK-9 ERVK-10 BMP1 MALT1 ERVK-19 ERVK-24 NRDC ADAM30 CFI ERVK-8 CORIN | 9.66e-04 | 430 | 192 | 12 | GO:0004175 |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 1.35e-03 | 6 | 192 | 2 | GO:0034647 | |
| Domain | Ser/Thr_kinase_AS | SLK ERN1 PBK ACVR1 RPS6KC1 STK32A BMPR1A BMPR1B CSNK1G1 MAP4K4 MAP3K8 MAP3K14 CSNK1G2 PRKCZ | 1.19e-05 | 357 | 183 | 14 | IPR008271 |
| Domain | S_TKc | SLK ERN1 PBK ACVR1 RPS6KC1 STK32A BMPR1A BMPR1B CSNK1G1 MAP4K4 MAP3K8 MAP3K14 CSNK1G2 PRKCZ | 1.27e-05 | 359 | 183 | 14 | SM00220 |
| Domain | PROTEIN_KINASE_ST | SLK ERN1 PBK ACVR1 RPS6KC1 STK32A BMPR1A BMPR1B CSNK1G1 MAP4K4 MAP3K8 MAP3K14 CSNK1G2 PRKCZ | 1.39e-05 | 362 | 183 | 14 | PS00108 |
| Domain | Pkinase | SLK ERN1 PBK ACVR1 RPS6KC1 STK32A BMPR1A BMPR1B CSNK1G1 MAP4K4 MAP3K8 MAP3K14 CSNK1G2 PRKCZ | 2.45e-05 | 381 | 183 | 14 | PF00069 |
| Domain | GS_dom | 3.15e-05 | 7 | 183 | 3 | IPR003605 | |
| Domain | GS | 3.15e-05 | 7 | 183 | 3 | PS51256 | |
| Domain | TGF_beta_GS | 3.15e-05 | 7 | 183 | 3 | PF08515 | |
| Domain | GS | 3.15e-05 | 7 | 183 | 3 | SM00467 | |
| Domain | PROTEIN_KINASE_ATP | SLK ERN1 PBK ACVR1 RPS6KC1 STK32A BMPR1A BMPR1B CSNK1G1 MAP4K4 MAP3K8 MAP3K14 CSNK1G2 PRKCZ MUSK | 4.85e-05 | 459 | 183 | 15 | PS00107 |
| Domain | S-AdoMet_synt_N | 9.55e-05 | 2 | 183 | 2 | PF00438 | |
| Domain | S-AdoMet_synthetase | 9.55e-05 | 2 | 183 | 2 | IPR002133 | |
| Domain | NECAP_PHear | 9.55e-05 | 2 | 183 | 2 | IPR012466 | |
| Domain | S-AdoMet_synt_M | 9.55e-05 | 2 | 183 | 2 | PF02772 | |
| Domain | S-AdoMet_synt_C | 9.55e-05 | 2 | 183 | 2 | PF02773 | |
| Domain | ADOMET_SYNTHASE_CS | 9.55e-05 | 2 | 183 | 2 | IPR022631 | |
| Domain | S-AdoMet_synt_C | 9.55e-05 | 2 | 183 | 2 | IPR022630 | |
| Domain | S-AdoMet_synthetase_sfam | 9.55e-05 | 2 | 183 | 2 | IPR022636 | |
| Domain | S-AdoMet_synt_central | 9.55e-05 | 2 | 183 | 2 | IPR022629 | |
| Domain | S-AdoMet_synt_N | 9.55e-05 | 2 | 183 | 2 | IPR022628 | |
| Domain | DUF1681 | 9.55e-05 | 2 | 183 | 2 | PF07933 | |
| Domain | ADOMET_SYNTHASE_1 | 9.55e-05 | 2 | 183 | 2 | PS00376 | |
| Domain | ADOMET_SYNTHASE_2 | 9.55e-05 | 2 | 183 | 2 | PS00377 | |
| Domain | Prot_kinase_dom | SLK ERN1 PBK ACVR1 RPS6KC1 STK32A BMPR1A BMPR1B CSNK1G1 MAP4K4 MAP3K8 MAP3K14 CSNK1G2 PRKCZ MUSK | 9.85e-05 | 489 | 183 | 15 | IPR000719 |
| Domain | JmjN | 1.06e-04 | 10 | 183 | 3 | SM00545 | |
| Domain | JmjN | 1.06e-04 | 10 | 183 | 3 | PF02375 | |
| Domain | Activin_recp | 1.06e-04 | 10 | 183 | 3 | PF01064 | |
| Domain | Activin_recp | 1.06e-04 | 10 | 183 | 3 | IPR000472 | |
| Domain | JMJN | 1.06e-04 | 10 | 183 | 3 | PS51183 | |
| Domain | JmjN | 1.06e-04 | 10 | 183 | 3 | IPR003349 | |
| Domain | PROTEIN_KINASE_DOM | SLK ERN1 PBK ACVR1 RPS6KC1 STK32A BMPR1A BMPR1B CSNK1G1 MAP4K4 MAP3K8 MAP3K14 CSNK1G2 PRKCZ MUSK | 1.08e-04 | 493 | 183 | 15 | PS50011 |
| Domain | TGFB_receptor | 1.91e-04 | 12 | 183 | 3 | IPR000333 | |
| Domain | CK1gamma_C | 2.85e-04 | 3 | 183 | 2 | PF12605 | |
| Domain | HAS/NodC | 2.85e-04 | 3 | 183 | 2 | IPR026107 | |
| Domain | Casein_kinase-1_gamma_C | 2.85e-04 | 3 | 183 | 2 | IPR022247 | |
| Domain | Kinase-like_dom | SLK ERN1 PBK ACVR1 RPS6KC1 STK32A BMPR1A BMPR1B CSNK1G1 MAP4K4 MAP3K8 MAP3K14 CSNK1G2 PRKCZ MUSK | 3.00e-04 | 542 | 183 | 15 | IPR011009 |
| Domain | Lys_sp_deMease-like_dom | 5.66e-04 | 4 | 183 | 2 | IPR013637 | |
| Domain | PLU-1 | 5.66e-04 | 4 | 183 | 2 | PF08429 | |
| Domain | zf-C5HC2 | 9.36e-04 | 5 | 183 | 2 | PF02928 | |
| Domain | Znf_C5HC2 | 9.36e-04 | 5 | 183 | 2 | IPR004198 | |
| Domain | Protein_kinase_ATP_BS | SLK ACVR1 STK32A BMPR1A BMPR1B CSNK1G1 MAP4K4 MAP3K14 CSNK1G2 PRKCZ MUSK | 1.32e-03 | 379 | 183 | 11 | IPR017441 |
| Domain | UmuC | 1.40e-03 | 6 | 183 | 2 | IPR001126 | |
| Pubmed | The type I BMP receptor ACVR1/ALK2 is required for chondrogenesis during development. | 1.68e-07 | 3 | 193 | 3 | 25413979 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | ERN1 MAT2A ACVR1 BMPR1A DIAPH2 MAP4K4 ANKRD52 TCTN1 FBXO34 REV1 VEZT CSNK1G2 TTI1 KDM4A ACCSL | 3.69e-07 | 536 | 193 | 15 | 15840001 |
| Pubmed | ERN1 MAT2A ACVR1 BMPR1A DIAPH2 MAP4K4 ANKRD52 TCTN1 FBXO34 REV1 VEZT CSNK1G2 TTI1 KDM4A ACCSL | 3.87e-07 | 538 | 193 | 15 | 10512203 | |
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 22971142 | ||
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 8605036 | ||
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 7983737 | ||
| Pubmed | ERCC4 SETX RPS6KC1 PHC3 BMPR1A VPS33B BAIAP3 NRDC POLR2B COPG2 BTLA GPR183 PRAMEF17 CUBN NPHP3 PPP3CB UNC5C HMGXB3 PRKCZ ACCSL TNS1 | 7.58e-07 | 1084 | 193 | 21 | 11544199 | |
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 30548566 | ||
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 27048979 | ||
| Pubmed | 2.65e-06 | 18 | 193 | 4 | 38111957 | ||
| Pubmed | Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. | 3.32e-06 | 6 | 193 | 3 | 8006002 | |
| Pubmed | NIK and Cot cooperate to trigger NF-kappaB p65 phosphorylation. | 3.32e-06 | 6 | 193 | 3 | 18439422 | |
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 25641697 | ||
| Pubmed | ACLY MRPL44 PBK NDUFA10 VPS33B HSP90AB1 IRS4 IPO7 NRDC COPB1 POLR2B COPG2 PPP1R10 WDR6 | 3.39e-06 | 560 | 193 | 14 | 35241646 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 12065756 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 18070108 | ||
| Pubmed | Differential expression of BMP receptors in early mouse development. | 5.79e-06 | 7 | 193 | 3 | 9303341 | |
| Pubmed | SIX4 CEMIP2 VPS33B MTUS1 ANKRD52 NOTCH1 HSP90AB1 IRS4 IPO7 VEZT POLR2B POLR2G COPG2 PPP1R10 PPP3CB SLC12A4 TTI1 TNS1 FTSJ3 | 6.87e-06 | 1049 | 193 | 19 | 27880917 | |
| Pubmed | 7.49e-06 | 23 | 193 | 4 | 14701881 | ||
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 7.67e-06 | 84 | 193 | 6 | 15203218 | |
| Pubmed | 7.81e-06 | 49 | 193 | 5 | 19161160 | ||
| Pubmed | 8.95e-06 | 24 | 193 | 4 | 21633169 | ||
| Pubmed | 9.23e-06 | 8 | 193 | 3 | 15671031 | ||
| Pubmed | 9.23e-06 | 8 | 193 | 3 | 8702914 | ||
| Pubmed | ACLY MAT1A MAT2A NSUN2 HSP90AB1 IRS4 IPO7 COPB1 POLR2B COPG2 ATIC ZNF682 | 9.30e-06 | 451 | 193 | 12 | 36168627 | |
| Pubmed | BmpR1A is a major type 1 BMP receptor for BMP-Smad signaling during skull development. | 1.38e-05 | 9 | 193 | 3 | 28641928 | |
| Pubmed | Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. | 1.38e-05 | 9 | 193 | 3 | 12857866 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.47e-05 | 94 | 193 | 6 | 21542922 | |
| Pubmed | 1.96e-05 | 10 | 193 | 3 | 15611116 | ||
| Pubmed | 1.96e-05 | 10 | 193 | 3 | 15239668 | ||
| Pubmed | 1.96e-05 | 10 | 193 | 3 | 18436533 | ||
| Pubmed | Modulation of activin signal transduction by inhibin B and inhibin-binding protein (INhBP). | 1.96e-05 | 10 | 193 | 3 | 11266516 | |
| Pubmed | 2.34e-05 | 102 | 193 | 6 | 9734811 | ||
| Pubmed | 2.69e-05 | 11 | 193 | 3 | 15289457 | ||
| Pubmed | 2.69e-05 | 11 | 193 | 3 | 7791754 | ||
| Pubmed | BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo. | 2.69e-05 | 11 | 193 | 3 | 20406889 | |
| Pubmed | Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling. | 2.69e-05 | 11 | 193 | 3 | 19758997 | |
| Pubmed | 2.69e-05 | 11 | 193 | 3 | 35842443 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 25516437 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 11739188 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 9016821 | ||
| Pubmed | NOTCH1 and DLL4 are involved in the human tuberculosis progression and immune response activation. | 3.06e-05 | 2 | 193 | 2 | 32801053 | |
| Pubmed | Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease. | 3.06e-05 | 2 | 193 | 2 | 23583836 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 17720279 | ||
| Pubmed | Hyaluronic acid, HAS1, and HAS2 are significantly upregulated during muscle hypertrophy. | 3.06e-05 | 2 | 193 | 2 | 22785117 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 9730621 | ||
| Pubmed | Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme. | 3.06e-05 | 2 | 193 | 2 | 23787764 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 10850425 | ||
| Pubmed | Ongoing Dll4-Notch signaling is required for T-cell homeostasis in the adult thymus. | 3.06e-05 | 2 | 193 | 2 | 21598246 | |
| Pubmed | A novel IgA/Delta-like 4/Notch axis induces immunosuppressive activity in human dendritic cells. | 3.06e-05 | 2 | 193 | 2 | 27117596 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 28357470 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 22318685 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 15322331 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 29175363 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 33803805 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 29749642 | ||
| Pubmed | Dynamic changes in cervical glycosaminoglycan composition during normal pregnancy and preterm birth. | 3.06e-05 | 2 | 193 | 2 | 22529214 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 20193271 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 29666622 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 27184066 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 32764110 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 20673479 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 26521733 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 31234428 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 26148958 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 29448301 | ||
| Pubmed | KDM5 lysine demethylases are involved in maintenance of 3'UTR length. | 3.06e-05 | 2 | 193 | 2 | 28138513 | |
| Pubmed | eNOS and XRCC4 VNTR variants contribute to formation of nicotine dependence and/or schizophrenia. | 3.06e-05 | 2 | 193 | 2 | 29050484 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 15102710 | ||
| Pubmed | Internalization of AMPA-type Glutamate Receptor in the MIN6 Pancreatic β-cell Line. | 3.06e-05 | 2 | 193 | 2 | 32581155 | |
| Pubmed | The Notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development. | 3.06e-05 | 2 | 193 | 2 | 21700774 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 31676012 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 34504875 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 35673977 | ||
| Pubmed | Simulation of the dynamics of primary immunodeficiencies in CD4+ T-cells. | 3.06e-05 | 2 | 193 | 2 | 28448599 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 33469672 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 30472020 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 27076759 | ||
| Pubmed | DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice. | 3.06e-05 | 2 | 193 | 2 | 25355291 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 24501215 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 23452080 | ||
| Pubmed | Notch1 regulates maturation of CD4+ and CD8+ thymocytes by modulating TCR signal strength. | 3.06e-05 | 2 | 193 | 2 | 11290335 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 34184733 | ||
| Pubmed | BMPR1A and BMPR1B Missense Mutations Cause Primary Ovarian Insufficiency. | 3.06e-05 | 2 | 193 | 2 | 31769494 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 36509829 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 35725756 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 25766473 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 19057901 | ||
| Pubmed | BMP signaling through ACVRI is required for left-right patterning in the early mouse embryo. | 3.06e-05 | 2 | 193 | 2 | 15531373 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 28855631 | ||
| Pubmed | BMPR1A-mediated BMP1 signalling is disrupted in the cadmium-induced omphalocele in the chick model. | 3.06e-05 | 2 | 193 | 2 | 21258932 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 23078267 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 26070613 | ||
| Pubmed | Hyaluronan deficiency in tumor stroma impairs macrophage trafficking and tumor neovascularization. | 3.06e-05 | 2 | 193 | 2 | 20823158 | |
| Pubmed | Dll4, a novel Notch ligand expressed in arterial endothelium. | 3.06e-05 | 2 | 193 | 2 | 10837024 | |
| Pubmed | KDM5B LONRF1 MAT2A NDUFA10 NSUN2 TRIM66 MAP4K4 HSP90AB1 COPB1 KDM5A WDR47 ARRB1 PPP3CB DNAJC14 TRIM9 PDE4DIP PPP1R16B KDM4A ATIC CADPS2 | 3.45e-05 | 1285 | 193 | 20 | 35914814 | |
| Pubmed | 3.57e-05 | 12 | 193 | 3 | 15913604 | ||
| Pubmed | 3.57e-05 | 12 | 193 | 3 | 25872870 | ||
| Pubmed | 3.57e-05 | 12 | 193 | 3 | 15282305 | ||
| Pubmed | 3.57e-05 | 12 | 193 | 3 | 14557543 | ||
| Interaction | AMHR2 interactions | 8.36e-07 | 56 | 187 | 7 | int:AMHR2 | |
| Interaction | STK35 interactions | 7.70e-06 | 30 | 187 | 5 | int:STK35 | |
| GeneFamily | Type 1 receptor serine/threonine kinases | 8.84e-06 | 7 | 116 | 3 | 345 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 4.72e-04 | 24 | 116 | 3 | 485 | |
| GeneFamily | Glycosyltransferase family 2 | 6.02e-04 | 6 | 116 | 2 | 428 | |
| GeneFamily | Immunoglobulin like domain containing | 1.54e-03 | 193 | 116 | 6 | 594 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | KDM5B SLK TRIM25 ACVR1 RRAGC RPS6KC1 CSGALNACT2 PER2 CLCN6 MTUS1 CSNK1G1 RIPOR1 NOTCH1 HSP90AB1 MAP3K14 WDR47 PDE4DIP GMEB1 KDM4A OGA | 1.92e-06 | 822 | 187 | 20 | M6782 |
| Coexpression | GSE17721_POLYIC_VS_CPG_6H_BMDC_UP | 1.44e-05 | 200 | 187 | 9 | M3943 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | KDM5B CCNDBP1 ACVR1 ADGRV1 PCTP RPS6KC1 ATP8A1 DIAPH2 MAP4K4 MAP3K8 MAP3K14 NPHP3 FRMD6 NCOA7 | 1.70e-05 | 504 | 187 | 14 | M2157 |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 1.87e-05 | 158 | 187 | 8 | M372 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | PRTG ADGRV1 BMP1 ATP8A1 MTUS1 CCDC141 SNX25 CORIN CADPS2 ACOXL | 5.57e-09 | 183 | 186 | 10 | 6847c1252d6bb105524f812658112517fd351eab |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | PRTG ADGRV1 BMP1 ATP8A1 MTUS1 CCDC141 SNX25 CORIN CADPS2 ACOXL | 7.59e-09 | 189 | 186 | 10 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | PRTG ADGRV1 BMP1 ATP8A1 MTUS1 CCDC141 SNX25 NCOA7 CADPS2 ACOXL | 9.27e-09 | 193 | 186 | 10 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | PRTG ADGRV1 BMP1 ATP8A1 MTUS1 CCDC141 SNX25 NCOA7 CADPS2 ACOXL | 9.27e-09 | 193 | 186 | 10 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.12e-07 | 190 | 186 | 9 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.17e-07 | 191 | 186 | 9 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.17e-07 | 191 | 186 | 9 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.17e-07 | 191 | 186 | 9 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.23e-07 | 192 | 186 | 9 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 1.23e-07 | 192 | 186 | 9 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 1.23e-07 | 192 | 186 | 9 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 1.28e-07 | 193 | 186 | 9 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.34e-07 | 194 | 186 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-07 | 198 | 186 | 9 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-07 | 198 | 186 | 9 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-07 | 199 | 186 | 9 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 9.35e-07 | 180 | 186 | 8 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | facs-Heart-LV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 182 | 186 | 8 | 6dff753d65ba45db81f3cc0c9f59e1779d490955 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.06e-06 | 183 | 186 | 8 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-06 | 186 | 186 | 8 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-06 | 186 | 186 | 8 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.24e-06 | 187 | 186 | 8 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.24e-06 | 187 | 186 | 8 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.40e-06 | 190 | 186 | 8 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.58e-06 | 193 | 186 | 8 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-06 | 194 | 186 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.64e-06 | 194 | 186 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-06 | 196 | 186 | 8 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-06 | 196 | 186 | 8 | 65e161fd672e37a5d10f28011bb422c4d7042d6a | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.91e-06 | 198 | 186 | 8 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.91e-06 | 198 | 186 | 8 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.98e-06 | 199 | 186 | 8 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.98e-06 | 199 | 186 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.98e-06 | 199 | 186 | 8 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.06e-06 | 200 | 186 | 8 | 65c83a3f6ee2a10bcb5b95076696232c6373a7b4 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.06e-06 | 200 | 186 | 8 | 40e969883bc302e8fbc6b6ab9814529dc1472902 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.06e-06 | 200 | 186 | 8 | ad9cdc82a647d379abc713a56db0e11bb6494106 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 4.45e-06 | 157 | 186 | 7 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.84e-06 | 159 | 186 | 7 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.51e-06 | 170 | 186 | 7 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.51e-06 | 170 | 186 | 7 | adb625124832b0786a590e8f75b61e7263a1e0d4 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 9.77e-06 | 177 | 186 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.01e-05 | 178 | 186 | 7 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-B_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 181 | 186 | 7 | 3510e0ecd4f098e8553946c44c2a49587d543755 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.13e-05 | 181 | 186 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.17e-05 | 182 | 186 | 7 | 6bd48c5d60a259719f65cacee4b8135247e78fa9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.26e-05 | 184 | 186 | 7 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.26e-05 | 184 | 186 | 7 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.30e-05 | 185 | 186 | 7 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 1.30e-05 | 185 | 186 | 7 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.30e-05 | 185 | 186 | 7 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.30e-05 | 185 | 186 | 7 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-05 | 185 | 186 | 7 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.35e-05 | 186 | 186 | 7 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.40e-05 | 187 | 186 | 7 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-05 | 188 | 186 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 189 | 186 | 7 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | Control-Epithelial-ATII|Control / Disease state, Lineage and Cell class | 1.55e-05 | 190 | 186 | 7 | d50902a3abcc18aafa36d83cc2c6e07d7f7cb197 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.60e-05 | 191 | 186 | 7 | 273c4a757292a9301de0eaeacdec91c9866be229 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.60e-05 | 191 | 186 | 7 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.60e-05 | 191 | 186 | 7 | f9a46956778a8773d6656340ecf5d218376d79c2 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.65e-05 | 192 | 186 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.65e-05 | 192 | 186 | 7 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 192 | 186 | 7 | 40f44ac4ab673ee6156abdd2074a60b9de3281ad | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.65e-05 | 192 | 186 | 7 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.65e-05 | 192 | 186 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.65e-05 | 192 | 186 | 7 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-05 | 193 | 186 | 7 | ba484fa1f290a92ae02475a4c468b4ac840c133e | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.77e-05 | 194 | 186 | 7 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.77e-05 | 194 | 186 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Control-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.77e-05 | 194 | 186 | 7 | a01de094f7bfd099bcbb2f94224690a2efb887b4 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.83e-05 | 195 | 186 | 7 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.83e-05 | 195 | 186 | 7 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.83e-05 | 195 | 186 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.95e-05 | 197 | 186 | 7 | 4a7ff67bb0754e034e6f2a1bd34cde86ee3ef899 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.02e-05 | 198 | 186 | 7 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | distal-mesenchymal-Mesothelial|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.02e-05 | 198 | 186 | 7 | 52e3cb45472dd6db31ae533e9ea0c3b550f11496 | |
| ToppCell | distal-mesenchymal-Mesothelial-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.02e-05 | 198 | 186 | 7 | 431bf719ee5cce4c9e8b6b405819b67e98fad3ca | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.02e-05 | 198 | 186 | 7 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | distal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.08e-05 | 199 | 186 | 7 | 8dd5b411d2f1626830b77a1616cc3fb67dc59338 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-05 | 199 | 186 | 7 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Mesothelial-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.08e-05 | 199 | 186 | 7 | 60a653100aff31f7f96796ff2ec634798bfb4b0d | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT2|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.08e-05 | 199 | 186 | 7 | 5323d49d3be980605b3e609b7f03bddba6e50e8a | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.08e-05 | 199 | 186 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.15e-05 | 200 | 186 | 7 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial-Astrocyte|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.15e-05 | 200 | 186 | 7 | 98a994692440cb4f505b050276f0c8022c814a21 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.15e-05 | 200 | 186 | 7 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.15e-05 | 200 | 186 | 7 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | medial-mesenchymal-Adventitial_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.15e-05 | 200 | 186 | 7 | 87a5a0c252c08ba10316c21f6a9d5244c4d98c74 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.15e-05 | 200 | 186 | 7 | ef222dc4a205d670172dae74990bdb952ac92e5b | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-05 | 200 | 186 | 7 | 6b48ddde83bc6c941d557844aa214d4d2c8e736d | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.15e-05 | 200 | 186 | 7 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | medial-2-mesenchymal-Adventitial_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.15e-05 | 200 | 186 | 7 | 6ccf44f10d2cee5f48b8f05bd9a1b94057184d56 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-05 | 200 | 186 | 7 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | medial-mesenchymal-Adventitial_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.15e-05 | 200 | 186 | 7 | 5ee1318a74ca28a81bd81c20c611de84c17636b0 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.56e-05 | 159 | 186 | 6 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 160 | 186 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 160 | 186 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Severe-Lymphoid-NK-|Severe / Condition, Lineage, Cell class and cell subclass | 5.76e-05 | 160 | 186 | 6 | d276c6cb8317d5fb19e7b4fe5238abaf0272d4c6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.17e-05 | 162 | 186 | 6 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| Drug | alkylbenzene | 1.25e-06 | 67 | 186 | 7 | CID000031237 | |
| Drug | fluorocitrate | 2.41e-06 | 27 | 186 | 5 | CID000107647 | |
| Disease | cancer (implicated_via_orthology) | ERCC4 ESRRG PHC3 NOTCH1 HSP90AA4P HSP90AB1 HSP90AB3P DLL4 POLR2G FRMD6 TTI1 | 1.07e-06 | 268 | 184 | 11 | DOID:162 (implicated_via_orthology) |
| Disease | lung large cell carcinoma (biomarker_via_orthology) | 3.87e-05 | 2 | 184 | 2 | DOID:4556 (biomarker_via_orthology) | |
| Disease | lung small cell carcinoma (biomarker_via_orthology) | 3.87e-05 | 2 | 184 | 2 | DOID:5409 (biomarker_via_orthology) | |
| Disease | Addicted to cocaine | 1.16e-04 | 3 | 184 | 2 | C0858355 | |
| Disease | Gastric Adenocarcinoma | 1.79e-04 | 45 | 184 | 4 | C0278701 | |
| Disease | lung adenocarcinoma (biomarker_via_orthology) | 2.30e-04 | 4 | 184 | 2 | DOID:3910 (biomarker_via_orthology) | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 2.30e-04 | 4 | 184 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | FANCONI ANEMIA, COMPLEMENTATION GROUP Q | 2.30e-04 | 4 | 184 | 2 | C3808988 | |
| Disease | Dwarfism | 4.96e-04 | 25 | 184 | 3 | C0013336 | |
| Disease | Adams Oliver syndrome | 5.71e-04 | 6 | 184 | 2 | C0265268 | |
| Disease | Congenital defect of skull and scalp | 5.71e-04 | 6 | 184 | 2 | C2931779 | |
| Disease | Adams-Oliver syndrome 1 | 5.71e-04 | 6 | 184 | 2 | C4551482 | |
| Disease | myotonic dystrophy type 1 (implicated_via_orthology) | 5.71e-04 | 6 | 184 | 2 | DOID:11722 (implicated_via_orthology) | |
| Disease | Adams-Oliver syndrome (is_implicated_in) | 5.71e-04 | 6 | 184 | 2 | DOID:0060227 (is_implicated_in) | |
| Disease | limb ischemia (is_implicated_in) | 5.71e-04 | 6 | 184 | 2 | DOID:0050852 (is_implicated_in) | |
| Disease | level of Sterol ester (27:1/22:6) in blood serum | 7.96e-04 | 7 | 184 | 2 | OBA_2045201 | |
| Disease | platelet component distribution width | SPTA1 TRPM3 ATAD2B PLCG2 NOS3 DLL4 DOK2 CUBN TNN PPP1R16B DEPDC7 MUSK ACOXL | 9.60e-04 | 755 | 184 | 13 | EFO_0007984 |
| Disease | cleft palate (implicated_via_orthology) | 1.06e-03 | 8 | 184 | 2 | DOID:674 (implicated_via_orthology) | |
| Disease | intellectual disability (implicated_via_orthology) | 1.26e-03 | 75 | 184 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | hemangiopericytoma (is_marker_for) | 1.35e-03 | 9 | 184 | 2 | DOID:264 (is_marker_for) | |
| Disease | PITUITARY DWARFISM I | 1.35e-03 | 9 | 184 | 2 | C0342573 | |
| Disease | egg allergy measurement | 1.35e-03 | 9 | 184 | 2 | EFO_0007018 | |
| Disease | level of Phosphatidylcholine (16:0_22:4) in blood serum | 1.35e-03 | 9 | 184 | 2 | OBA_2045078 | |
| Disease | coronary artery disease | IFT140 SLK MAT2A BMP1 FNDC1 BMPR1B VPS33B TRPM3 PLCG2 NOS3 HOMER2 FNDC3B SPECC1L ZBED6 CSNK1G2 UNC5C TNS1 | 1.36e-03 | 1194 | 184 | 17 | EFO_0001645 |
| Disease | Nonsyndromic Deafness | 1.67e-03 | 81 | 184 | 4 | C3711374 | |
| Disease | thiamine measurement | 1.68e-03 | 10 | 184 | 2 | EFO_0010540 | |
| Disease | response to carboplatin, response to antineoplastic agent | 1.68e-03 | 10 | 184 | 2 | GO_0097327, GO_0097328 | |
| Disease | alopecia areata (is_marker_for) | 1.68e-03 | 10 | 184 | 2 | DOID:986 (is_marker_for) | |
| Disease | trochanter bone mineral density | 1.68e-03 | 10 | 184 | 2 | EFO_0020095 | |
| Disease | electrocardiography | 1.91e-03 | 530 | 184 | 10 | EFO_0004327 | |
| Disease | mean platelet volume | SPTA1 STARD10 BACE1 PFKFB4 GRAMD1B TRPM3 ATAD2B RIPOR1 PLCG2 NOS3 FBXO34 NRDC DOK2 PPP1R16B MUSK | 1.91e-03 | 1020 | 184 | 15 | EFO_0004584 |
| Disease | corneal resistance factor | PRTG CSGALNACT2 TRPM3 HSP90AB3P FNDC3B COL6A2 LPAR1 NPHP3 TNS1 | 2.19e-03 | 451 | 184 | 9 | EFO_0010067 |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 2.45e-03 | 12 | 184 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | arachidonoylcarnitine (C20:4) measurement | 2.45e-03 | 12 | 184 | 2 | EFO_0800544 | |
| Disease | right ventricular stroke volume measurement | 2.45e-03 | 12 | 184 | 2 | EFO_0021817 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 2.88e-03 | 13 | 184 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Connective Tissue Diseases | 2.88e-03 | 13 | 184 | 2 | C0009782 | |
| Disease | Craniofacial Abnormalities | 3.02e-03 | 156 | 184 | 5 | C0376634 | |
| Disease | IGF-1 measurement | 3.69e-03 | 488 | 184 | 9 | EFO_0004627 | |
| Disease | Alzheimer's Disease | 3.73e-03 | 101 | 184 | 4 | C0002395 | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 3.77e-03 | 50 | 184 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | cognitive inhibition measurement | 3.77e-03 | 50 | 184 | 3 | EFO_0007969 | |
| Disease | opioid dependence | 3.82e-03 | 237 | 184 | 6 | EFO_0005611 | |
| Disease | delta-6 desaturase measurement | 3.85e-03 | 15 | 184 | 2 | EFO_0007765 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 3.85e-03 | 15 | 184 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 4.38e-03 | 16 | 184 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | level of triacylglycerol (56:6) in blood serum | 4.38e-03 | 16 | 184 | 2 | OBA_2020007 | |
| Disease | colorectal mucinous adenocarcinoma | 4.38e-03 | 16 | 184 | 2 | EFO_0009361 | |
| Disease | Pre-Eclampsia | 4.38e-03 | 16 | 184 | 2 | C0032914 | |
| Disease | Eye Abnormalities | 4.95e-03 | 17 | 184 | 2 | C0015393 | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 4.95e-03 | 17 | 184 | 2 | DOID:10873 (is_implicated_in) | |
| Disease | Ciliopathies | 5.06e-03 | 110 | 184 | 4 | C4277690 | |
| Disease | acute pancreatitis | 5.54e-03 | 18 | 184 | 2 | EFO_1000652 | |
| Disease | C-X-C motif chemokine 16 measurement | 5.54e-03 | 18 | 184 | 2 | EFO_0010911 | |
| Disease | Meckel syndrome type 1 | 5.54e-03 | 18 | 184 | 2 | C3714506 | |
| Disease | reticulocyte count | ACLY SPTA1 ACVR1 ATAD2B PLCG2 BAIAP3 FBXO34 HSP90AB1 FNDC3B COPB1 TSPAN32 SLC22A16 NCOA7 TNS1 | 6.07e-03 | 1045 | 184 | 14 | EFO_0007986 |
| Disease | blood metabolite measurement | 6.17e-03 | 19 | 184 | 2 | EFO_0005664 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 6.17e-03 | 19 | 184 | 2 | C1333991 | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 6.17e-03 | 19 | 184 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | reasoning | 6.17e-03 | 19 | 184 | 2 | EFO_0004350 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 6.17e-03 | 19 | 184 | 2 | C2936783 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ESDMNCIEDTLLQYP | 191 | Q4AC99 | |
| SETMPLYTLCKEDLE | 841 | Q9Y5B0 | |
| VTLDMEDCGYNIPQT | 436 | P56817 | |
| MIEAEEQQPCKTDFY | 1 | Q6DHV7 | |
| DVVCYTQKADSPMDD | 211 | P05156 | |
| FEICPFESELNMDIA | 551 | O94812 | |
| MQEGSEVYSNPCLEE | 236 | Q7Z6A9 | |
| VESMPLCYIKTDITE | 381 | Q58F21 | |
| EEYEPELCRQMTKTI | 96 | Q8N7M0 | |
| SLTKVDEAEYMCPDG | 116 | Q14832 | |
| YSQASELPTDAVDCM | 421 | Q9NWN3 | |
| EKLMCPQEIVDYIAD | 136 | O14561 | |
| YMAPEVLDETIQVDC | 381 | Q04771 | |
| ILDTEPEMDEYFVCT | 3156 | Q8WXG9 | |
| SEDYASCSDMDLLNP | 306 | Q9C0F1 | |
| SMDNLDSECSEVYQP | 341 | Q69YQ0 | |
| PRDSMYQSVCLISEE | 661 | Q9NR61 | |
| AETDVEEIYHPVMCT | 246 | Q56P03 | |
| EEIYHPVMCTECSTE | 251 | Q56P03 | |
| VCLDATMPRVSEDVY | 286 | P43155 | |
| DCLEYLPDQMVVEIS | 271 | Q96QD5 | |
| EMSFNCLEDVESTIP | 571 | Q8NB46 | |
| YDDLCEPEQFGVVMS | 771 | O60879 | |
| EMDIESQPECAYDHL | 791 | P13497 | |
| VPSDPSYEDMREIVC | 431 | O00238 | |
| RASCEALYSEMDPEE | 781 | Q00975 | |
| TAQYKCPVAMEEADD | 246 | P49407 | |
| DFNTMGYCEEIPVEE | 241 | Q3KR37 | |
| EPQAMCYIETSNLDG | 176 | Q9Y2Q0 | |
| EFVIDTPCENAEKMY | 116 | Q9NUZ1 | |
| EAIYCDDMPLVDQEL | 596 | Q06278 | |
| TICQEEYSEAPNEMV | 106 | Q9Y483 | |
| MNTEGEIYDDCIVTV | 356 | Q7Z6M1 | |
| MDTPLLDTEEEVHYC | 161 | Q17RG1 | |
| MVYSTCSLNPIEDEA | 316 | Q08J23 | |
| MYCPEDIRTSQIDTL | 771 | Q6NSI4 | |
| YCQPEEEVARLLTMA | 421 | Q6Y2X3 | |
| FIMDSCDELIPEYLN | 361 | P08238 | |
| PNTDGMELLVCYEDE | 1126 | O95819 | |
| PCMEENELYSSAVTV | 131 | O60496 | |
| ADQDMECLSQYPSLS | 306 | Q5VTA0 | |
| YCTEDVDECQLMPNA | 291 | P46531 | |
| EANEDMEIAYPITCG | 86 | Q9Y692 | |
| IMCDAYVTDFPLDLD | 626 | Q9UDY8 | |
| ESAECLEMTYVPNID | 646 | Q9ULD2 | |
| MYCAPEVGAITEETE | 966 | Q96S38 | |
| RVFIMDSCDELIPEY | 301 | Q58FF7 | |
| EVCMFSLAYGDIPEE | 456 | Q17RB8 | |
| YATDETEECMPLTIV | 141 | P31153 | |
| ETMYSELPEEVKCIF | 871 | Q9ULI0 | |
| IIPQLMSECEYVSEK | 276 | Q9NSB8 | |
| EALCENFPEEMATYL | 276 | Q9HCP0 | |
| IEVLCENFPEEMATY | 276 | P78368 | |
| SYQCELTVDDIMPAV | 516 | P56696 | |
| DIENCSNMAPLYSDS | 191 | Q92633 | |
| CPELLDQHYTVDMTE | 1141 | Q12766 | |
| VIDIMENLYASEEPA | 26 | P41279 | |
| ESTMNEYIEQRKPCD | 726 | P42262 | |
| CGADVPSYTVEEMES | 166 | O15055 | |
| QDVIFPLMCYTDADE | 351 | O95373 | |
| VIQKMICEYSEEVTP | 561 | O95373 | |
| ICEYSEEVTPIAVEM | 566 | O95373 | |
| EYDVCMEPAKTLIEF | 316 | Q9UHC1 | |
| DTPCNEMNTDTFLEE | 186 | Q8NDH3 | |
| DIHIDIMDYIQPATC | 821 | P53618 | |
| IMDYIQPATCTDAEF | 826 | P53618 | |
| VCEEMTYEEIQDNYP | 331 | Q16877 | |
| PKEDLSSEQYEMTEC | 416 | O75164 | |
| SSEQYEMTECPAALA | 421 | O75164 | |
| YATDETEECMPLTII | 141 | Q00266 | |
| VCVGVSPEMAEKEDY | 1516 | Q9UGL1 | |
| LTAYLPAMSEDDEDC | 331 | Q6A1A2 | |
| MRPVLESEEELYSSC | 1186 | P16885 | |
| PYEECQTLIDEMVNT | 26 | P29728 | |
| YQVEDVCEEEMPEES | 586 | Q8NDX5 | |
| VGVSPEMAENEDYIC | 1641 | P29375 | |
| LPEMSEKCEVLQYSA | 246 | O95299 | |
| FDPRVLCMDEYDVVS | 546 | P29474 | |
| IPEDDAIYQCMAENS | 386 | Q2VWP7 | |
| DEPTLDVIETCMAYQ | 176 | Q96T49 | |
| EGMYPSICVEATESL | 106 | Q8NHR9 | |
| EDCSPTLLADIYMDS | 61 | Q9UKL6 | |
| NSDDPEAVMYVCKVA | 476 | Q02218 | |
| DLEPQDSCIMAYDGL | 1556 | O60494 | |
| VSVDKEPMADSCIYE | 306 | O95876 | |
| ETESLHCEYVAEPVM | 126 | P87889 | |
| ETESLHCEYVAEPVM | 126 | Q9YNA8 | |
| ETESLHCEYVAEPVM | 126 | P63145 | |
| ETESLHCEYVTEPVM | 126 | Q9HDB9 | |
| ETESLHCEYVAEPVM | 126 | P62685 | |
| ETESLHCEYVAEPVM | 126 | P63126 | |
| ESLEVSPDMCIYITE | 471 | Q96NE9 | |
| ETESLHCEYVAEPVM | 126 | P62684 | |
| MEAPSECYDAVNLIG | 516 | Q9UKF2 | |
| ADELTPEQYRMCIQS | 491 | Q8N6G5 | |
| CINDPYLEVLETMDN | 56 | P51797 | |
| SNLSSVEMYDPETDC | 536 | O94889 | |
| LPEDMLSGEEYECVS | 1196 | Q6ZP82 | |
| EMLSEDCKENPTYTV | 741 | O75460 | |
| MEQAVEECDPYSGLL | 191 | O95273 | |
| YTMVELCSEDDTLPA | 496 | Q9Y6R7 | |
| MAAYPESCVDTTVLD | 1 | Q96RJ6 | |
| CEVSEYSVEMTEPED | 701 | Q53EP0 | |
| LIMSSNGIPECYAEE | 1526 | Q4ZHG4 | |
| STIVEDPQTKCEYML | 106 | P62508 | |
| EESGIAICTMVYPSD | 191 | P51686 | |
| DPGLTECDVMTYVRE | 586 | P12110 | |
| DYVQVCDSDTMLDPA | 206 | Q92819 | |
| VPSDPSYEDMREVVC | 461 | P36894 | |
| AECPAITRMYEESAL | 1226 | Q6ZUT9 | |
| APNRIVYCTMEVEGE | 381 | Q86UW7 | |
| SMYQAEEFTLLPCSE | 441 | Q9UHN6 | |
| DNQTCLMPDEYVEEC | 566 | Q9Y5Q5 | |
| VQMEPSDSYEVLSCI | 676 | Q9UBF2 | |
| DYVQVCDSDTRLDPM | 231 | Q92839 | |
| IEASDNTVTICMDYI | 206 | Q9NUK0 | |
| DDDLYSCMVENPISQ | 211 | Q14CZ8 | |
| VCGMLYTASNPEDET | 621 | Q5FWF5 | |
| RDLIMDNCEELIPEY | 171 | Q58FG1 | |
| PYRCDLSNEEDILSM | 66 | Q6UWP2 | |
| ERVYEACMEAFDSLP | 181 | P16298 | |
| ECGYSVQVISMEPES | 606 | Q8NEC7 | |
| LCETPVLAMHEENVY | 481 | Q96RY7 | |
| LSDLPSCYMSDIEFE | 311 | Q96DY7 | |
| TEIMYTLQEPIDCTC | 2336 | Q3ZCN5 | |
| LYPREDMEAVSLTCD | 156 | Q16557 | |
| YDMEVPDSGIDLQCT | 911 | Q99558 | |
| SPILALSCMDTYDIE | 181 | Q8NGG4 | |
| YVVDPFSECCMDISL | 1046 | O14654 | |
| ITVTQYDPEEDCRKM | 4306 | Q685J3 | |
| METDYVEALTPICIS | 531 | A6NES4 | |
| LHRIQYEMPLCDEES | 86 | Q5VXT5 | |
| CLTQFLEDEYPDMPT | 136 | Q9H9J2 | |
| ATDSSPVDMQSYELC | 271 | Q9HB90 | |
| YMVEIDILASCDHPN | 76 | Q9H2G2 | |
| RMECCDVPAETLYDV | 71 | Q9Y365 | |
| EPDKCNIAVEEEYMT | 51 | Q8NI08 | |
| EDIETDVLYSPQMAL | 366 | O60502 | |
| RCYLIYTDETQPEMD | 301 | Q7Z494 | |
| EENGEQLPCYFVMVS | 521 | Q9H3E2 | |
| VVEIPAYTFVCIAMD | 396 | Q86VW1 | |
| AERITCMEYPNFEET | 176 | P32249 | |
| SCLKTEIMSPLYQDE | 576 | Q8IY81 | |
| AMTPDDLQEKEVAYC | 676 | P30876 | |
| YVLDGMVDTVCEDLE | 746 | Q9UIU6 | |
| EPESYLDDMVTCSQI | 341 | Q7Z333 | |
| CENRISDYMDLTPVD | 346 | Q8IXF0 | |
| EPYLCDSQVSTFTME | 146 | Q8NEM2 | |
| NCDPTFELEEMILES | 306 | Q8WU08 | |
| TYVPCLKTLQEEVME | 186 | Q96A35 | |
| DSCDPYFMLNNVTEI | 351 | Q9UP95 | |
| ETESLHCEYVAEPVM | 126 | P63128 | |
| DYVCSRDEPSVAAMV | 516 | P53396 | |
| LETLQSVRPCFMDEY | 231 | Q96AJ1 | |
| SVRPCFMDEYEKTEE | 236 | Q96AJ1 | |
| MLENTECHSIYEESP | 361 | O94967 | |
| PCYKTMDEDIVIQQD | 126 | P62487 | |
| DPMEEDILQVVKYCT | 1181 | Q9UBZ9 | |
| DASRPLQVYCDMETD | 1091 | Q9UQP3 | |
| PEYDDCMFSRVLTLD | 1201 | Q8NDV3 | |
| EFPDYCTPEVTEMIA | 286 | O15370 | |
| PTQVEDAMLDTYDLV | 116 | Q96QS1 | |
| PSSCIDIYVSAMDEL | 1421 | Q9HCF6 | |
| ALSECYTVASVAEMP | 471 | Q14258 | |
| AICSEMTADRDPVYD | 216 | Q13426 | |
| TMEDSCELDLVYVTE | 6 | Q9HBL0 | |
| MASAELDYTIEIPDQ | 1 | Q6P2H8 | |
| CEEIEALSMAFYSSP | 256 | Q2MV58 | |
| DLESCYAQVCLPEMV | 136 | Q8N9M5 | |
| YTEDLLPEQCMQDSF | 81 | O95780 | |
| QVAEPEACDQMYESL | 46 | Q9BRT2 | |
| QEQTDPVEYVENMCE | 556 | O43847 | |
| ISEMLPTACDESYKD | 1516 | P02549 | |
| NMTVTDPEACYIGTE | 196 | Q96KB5 | |
| CEPEDYVVVSTEMQS | 146 | P31939 | |
| VDPETRYMSLAVCEL | 856 | Q9NNW5 | |
| LMEYCLEVIKENDPS | 366 | Q9C026 | |
| SIIECDMNVDFDAPL | 181 | Q92890 | |
| AEEVCNYMESSPEIC | 796 | P86452 | |
| MPELYTEDFIQGCDV | 1 | Q09FC8 | |
| EDPETCLQLNMVYQE | 81 | Q5SXM2 | |
| GPMCVQIEDYSQVRD | 296 | O43895 | |
| LEVGDYILTPEMCVE | 711 | Q92889 | |
| AEERMCYQCESEDEP | 686 | Q9HBM0 | |
| TTDSPLYEECVRMND | 171 | Q6PF06 | |
| QAVRYSLCSEESPEM | 131 | Q9H8Y1 | |
| SLTQPEMEYDCENAC | 1016 | O15016 | |
| YTESMCLLESELEAQ | 191 | Q6ZS17 | |
| PLDEECSMDETPYVE | 521 | Q96QC0 | |
| LYPEAQVCDDIMESN | 1921 | P01266 | |
| LCMQTAPDSDDVALY | 366 | O95185 | |
| LCMEEYVIEPKSVQF | 126 | Q96GM8 | |
| SPQKFYACEMVLEEE | 116 | Q9H267 | |
| YLVTCLETEEMGEEL | 571 | O43156 | |
| DPCTVSSQMELEEAF | 66 | Q05513 | |
| DINATVALDFECPMT | 356 | Q9NR99 | |
| VALDFECPMTRENYE | 361 | Q9NR99 | |
| VEEVATFMCAVESYP | 41 | O15146 | |
| LDPDVVYLMLSECDF | 61 | Q86UW6 | |
| ELEACSDMDIVSEYT | 1616 | Q5VU43 | |
| EMAVCPEQLSEFLDS | 291 | Q7Z6G3 | |
| MATELEYESVLCVKP | 1 | Q8NC96 | |
| MEESGYESVLCVKPD | 1 | Q9NVZ3 |